征稿截止日期： 1 April 2022 at 18:00hrs CEST.

点此提交摘要>>>Submit Abstract>>>

Communications must be delivered in English. There is no simultaneous translation.

It is not permitted to take photographs and/or film during any of the sessions.

Receipt of Abstract

Abstracts can only be submitted online and MUST be submitted BEFORE 1 APRIL 2022 18:00hrs CEST. THIS DEADLINE WILL BE STRICTLY ENFORCED, as will be the regulations given below. The EASD office will notify the presenting (= first named) author when the abstracts with the status "complete" are forwarded for anonymous review.

Submission of Abstracts

The following is a brief overview of the abstract submission process. Please read carefully the: 提交指南/DETAILED ABSTRACT SUBMISSION GUIDELINES before you begin the abstract submission process.

It is not permitted to submit work that has been published and/or is likely to be published before the EASD Abstract submission deadline (1 April 2022, 18:00hrs. CEST). The Programme Committee has the right to remove an abstract if this contains data that has already been published. However, EASD accepts the submission of abstracts that have been presented in recent months at local or national diabetes meetings (e.g. ADA, DDG). An author submitting or presenting work that has been published in a journal before the EASD Abstract submission deadline (1 April 2022, 18:00hrs CEST) will be banned from presenting data at the EASD Meetings for three years.

Abstracts submitted on Human Studies:

The box must be marked stating that the study has been reviewed by the Local Ethics Committee and that it has therefore been performed in accordance with the ethical standards laid down in the Helsinki Declaration (see World Medical Association: www.wma.net).

Abstracts submitted on Animal Studies:

The box must be marked stating that the study has been carried out along the “Principles of laboratory animal care” (NIH Publication no. 85-23, revised 1985) and according to the national law, if applicable.

Selection of abstracts for the Scientific Programme is made anonymously. THE ABSTRACT MUST BE SUBMITTED as follows:

Each author can be listed ONLY ONCE as the PRESENTING author (presenting author is always the first named author in the author block) on ONE (1) abstract. Each additional abstract will be removed from the system and will not be forwarded to the Review Committee. Additional abstracts will not be reviewed. Presenting authors may be co-authors of other abstracts. It is mandatory that the presenting author of any abstract accepted for presentation or discussion attends the 58th EASD Annual Meeting 2022 in Stockholm to present and/or discuss his/her paper. Failure to do so, without prior or adequate explanation sent to the EASD Office by e-mail, may result in the author or the institution being banned from presenting abstracts for the next three years.

Abstracts are welcome from non-members of EASD. Please refer to the Registration section of this General Information, regarding the date by which authors must become members of EASD in order to qualify for preferential registration fees. These regulations will be strictly enforced.

The abstract must be submitted in English. New authors should create an MyEASD account using their email address and a password. With this information they can revise the submission as often as required, make changes, additions, amendments, change/add/delete authors, copy special characters easily into the text, re-write the abstract or copy and paste the text in the corresponding boxes. All this is possible until the Abstract Submission Deadline: 1 April 2022 18:00hrs CEST. After this date the submission site will be closed. IMPORTANT!: Always double check that the “complete” status of your submitted abstract has NOT been affected after having edited it.

CHANGES TO THE CONTENT AND/OR THE AUTHOR BLOCK OF THE SUBMITTED ABSTRACT WILL NOT BE ACCEPTED after the submission deadline.

Your abstract submission must adhere the following structure:

• The maximum number of characters is 3,200 (excl. spaces) including the title and the author block. The title should be short (maximum 150 characters).
• Please enter your name and the names of co-authors as given in the example below. Start each name with a capital letter and continue in lower case, do not enter names/affiliations all in capital letters.
  First Name: John
  2nd Initial:  J
  3rd Initial:   R
  Last Name: Macleod
• The abstract must be structured. Enter each section into the corresponding text field with the provided sub-headings in bold (Background and aims:, Materials and methods:, Results: and Conclusion:). The abstract structuring words are fixed for each abstract text box. One or two sentences should describe the methods, and any aspects of methodology (e.g. use of control groups, randomisation, patient selection, assay variation). The sentences stating the results must include hard data, including statistical analysis. The abstract requires solid data, i.e. n, p-values and confidence intervals if appropriate.
• It is allowed to include only one table OR one graph to your abstract, but 400 characters will be deducted from the maximum number of characters allowed. Tables must be uploaded as an image; so you must create your table and convert it into an image in order to include it in your abstract. You can edit your table or graph and then replace it, or delete it until the submission deadline of 1 April 2022, 18:00hrs CEST. Do not enter both (a table and a graph) in the same image file; also, do not create and upload multi panel images (a maximum of two panels is allowed). When creating a table, do not exceed a number of 10 columns and 12 rows with a maximum of 1 line per row! 
• References are not allowed.
• For drugs exclusively generic names should be used (no trademarks).
• A list of approved abbreviations and units of expression for use without definition appears in Diabetologia.
• Grant/Support information must be entered into its designated field.
• Where applicable, the Clinical Trial Registration Number must be entered into its designated field; not in the abstract body.
• Only one keyword can be selected.
• Abstracts CANNOT be submitted as an e-mail attachment.

Once all submission steps have been successfully completed and the abstract deadline has passed, the presenting author will receive a notification confirming the final version of the abstract submission. In case of questions, or if you have not received a notification confirming the final version of the abstract submission by 19 April 2022, please contact the EASD office: abstracts@easd.org

Keywords

One keyword from the list below must be selected for the submission:

Programme Committee

Preference for oral presentation or short oral discussion is not possible. The Programme Committee allocates the accepted abstracts to either an oral presentation or a short oral discussion session. The Programme Committee Members will meet in May 2022 and have the absolute right to accept or reject abstracts. Their decision is final. Only accepted abstracts will be published in the Abstract Volume. The Programme Committee’s decision will be communicated via email in the last week of May 2022 ONLY to the presenting (= first named) author’s contact e-mail entered in the online abstract submission tool.

Short Oral Discussions

Short oral discussions rank equally with oral presentations at the EASD Annual Meeting. A short PowerPoint presentation without audio must be uploaded to the EASD presentation management platform by the indicated deadline prior to the start of the Annual Meeting. Detailed instructions will be sent to the presenting author on notification of acceptance (ONLY to the presenting (= first named) author’s contact e-mail entered in the online abstract submission tool) online abstract submission tool).

Oral Presentations

PowerPoint presentation will be available for Oral Presentations. Instructions on presentation will be sent to the presenting authors on notification of acceptance (ONLY to the presenting (= first named) author’s contact e-mail entered in the online abstract submission tool). Only single projection is provided.

Oral Presentations during the EASD Annual Meeting will be delivered live; they will also be made available as webcasts via the EASD Virtual Meeting.

Publication of Abstracts

Accepted abstracts will be published in the Abstract Volume, a supplement issue of Diabetologia, the journal of the EASD. Furthermore abstracts accepted for presentation and discussion will be published on the Association’s website www.easd.org from 1 July 2022.